A detailed history of Umb Bank, N.A. transactions in Glaukos Corp stock. As of the latest transaction made, Umb Bank, N.A. holds 114 shares of GKOS stock, worth $15,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114
Previous 53 115.09%
Holding current value
$15,782
Previous $6,000 133.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$113.62 - $135.39 $6,930 - $8,258
61 Added 115.09%
114 $14,000
Q2 2024

Jul 29, 2024

BUY
$89.48 - $118.35 $2,952 - $3,905
33 Added 165.0%
53 $6,000
Q1 2024

Apr 26, 2024

BUY
$76.4 - $96.33 $1,528 - $1,926
20 New
20 $1,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.59B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.